Texas Biotech funds Berlin subsidiary

TXB said its 55.2 percent owned subsidiary, Revotar Biopharmaceuticals, raised DM10 million ($4.7 million) through equity investments from BMP and Mediport, and that it expects an additional DM20 mill...